Abstract:Background Estimating the disease prevalence and test accuracy (sensitivity and specificity) for two dependent screening tests when the status of individuals who are negative on both tests is unverified represents a considerable challenge, as the disease rates for individuals negative on both tests are not identifiable without additional assumptions. Methods This article presents a unified framework for handling this non-identifiability problem using two-step hierarchical informative prior on the sensitivities by two-stage Bayesian modeling with the characterized by joint testing strategies based on the inherent attribute of screening/diagnostic tests. We assign a diffuse and less risky two-step hierarchical informative uniform prior to the sensitivities while assigning a uniform (0,1) prior distribution to the specificities and prevalence. Strategies for model evaluation, general global evaluations, and individual cell checking are presented. Simulations are conducted under various scenarios to evaluate the performance of the proposed method. Applications to real data are also presented to illustrate the potential impact and benefit of the proposed method. Results Our results indicate that when the priors of sensitivities are assigned as appropriate two-step hierarchical informative priors, or even in the absence of the priors for the specificities and prevalence, the parameters involved in this study can still be estimated well. The advantages and limitations of this method in solving such problems are discussed and compared with other two-stage methods. Conclusions We developed a two-stage Bayesian method for two dependent dichotomous screening tests with unverified individuals who are negative on both tests, and addressed the ad hoc model evaluation and checking procedures. The method can be understood easily and used conveniently by non-statisticians.

The Methods and SAS Program to Estimation of Bayesian Prior Parameters of Diagnostic Test in the Absence of the Gold Standard

A1362 Bayesian Estimation on Diagnostic Performance of Dementia Screening Tests in the Absence of a Gold Standard

Variance Analyzed under E-Bayesian Estimation and Hierarchical Bayesian Estimation for Diagnosing Failure Rates

Bayesian Hypothesis Tests Using Nonparametric Statistics

Bayesian bivariate meta-analysis of diagnostic test studies with interpretable priors

A Software Tool for Estimating Uncertainty of Bayesian Posterior Probability for Disease

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

A Two-Stage Bayesian Method for Estimating Accuracy and Disease Prevalence for Two Dependent Dichotomous Screening Tests when the Status of Individuals Who Are Negative on Both Tests is Unverified

A Priori Determination of the Pretest Probability

A Bayesian approach on sample size calculation for comparing means.

The application of Bayesian method in estimating heterogeneity of treatment effect

A comparison of Bayesian and score methods for interval estimates of positive/negative likelihood ratios in support of diagnostic device performance evaluation

Interval Estimation for the Difference in Paired Areas under the ROC Curves in the Absence of a Gold Standard Test

Estimating the Sampling Distribution of Posterior Decision Summaries in Bayesian Clinical Trials

Nonparametric receiver operating characteristic curve analysis with an imperfect gold standard

Estimation of ROC Curve with Multiple Types of Missing Gold Standard

The Evaluation of Some Two-stage Sampling Methods

A Non-Parametric Method for the Comparison of Partial Areas under ROC Curves and Its Application to Large Health Care Data Sets.

Reference interval estimation: Methodological comparison using extensive simulations and empirical data

Empirical Bayes Methods for Prior Estimation in Systems Medicine

Bayes Factor in One-Sample Tests of Means with a Sensitivity Analysis: A Discussion of Separate Prior Distributions